Degraders of the dengue virus capsid protein exhibit differentiated pharmacology relative to capsid inhibitors

Journal:

Nature Communications

Published:

2026-02-10

DOI:

10.1038/s41467-026-69263-w

Affiliations:

5

Authors:

10

Go to article

Institutions	Authors	Share
Stanford University, United States of America (USA)	8.000000	0.80
Harvard Medical School (HMS), United States of America (USA)	1.000000	0.10
Dana-Farber Cancer Institute (DFCI), United States of America (USA)	1.000000	0.10

Interested in Medical Microbiology?